Prescription Drug Monitoring Program - Data Disclosure to Federal Law Enforcement - Limitation

HB 1045 modifies Maryland’s Prescription Drug Monitoring Program (PDMP) by adding a restriction on sharing prescription data with federal law enforcement. Specifically, it amends Section 21-2A-06(b)(4) of the Maryland Annotated Code to prohibit disclosure to federal agencies unless the data does not involve "sensitive health services" designated by the new Protected Health Care Commission. This Commission, established under Section 4-310, will identify health services (like reproductive care) where data sharing could risk patient safety or privacy. The bill directly affects healthcare providers and patients whose data might be monitored, particularly for sensitive health services, by requiring a review before federal disclosure.